Add deal

The next league table publication is coming up! Deadline for submitting and editing deals is April 3rd, 2026.

← to Company overview

Biotech Fund Flanders

Year founded

-

Country of origin

Netherlands

HQ country

Netherlands

Total deal value

Login to see more

Average deal value

Login to see more

Company industry

  • Venture Capital

M&A expertise

  • Venture Capital Management

Industry expertise

  • Venture Capital
Company background

-

Latest deals
Aphea.Bio raised €70 million in Series C Investment round 11-07-2023 € 70 million ActoGenix raises EUR 13.5 million in series B investment round 11-02-2009 € 13.50 million ActoGenix raises EUR 11.5 million in Series A investment round 08-02-2007 € 11.50 million Devgen raises EUR 23 million in Series B investment round 01-10-1999 € 23 million Show all 4 deals
Contact information

Want to see more?

Interested to see more details? Get your Dealmaker subscription today!

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login

Almost there!

You are only one step away from access to the most comprehensive deal database of the Netherlands and Belgium.

Start optimising your deal analysis Start optimising your deal analysis

Already have an account? Please login